Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

Lilly and GRACE Partnership
dbrock
Visit our partnership page between Lilly Oncology and GRACE!
Author
Denise Brock
Image
GRACE is excited to share with you a partnership with Lilly Oncology to provide you information that reflects our shared interests. 

We are happy to launch our Partnership Page with Lilly Oncology, available at https://cancergrace.org/sponsor/lilly-2020.  This partnership highlights past and present GRACE information featuring our shared interests. 

For more than 50 years, Lilly Oncology has been dedicated to life-changing medicines and support to people living with cancer and those who care for them.   Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world.  We share that commitment and appreciate the opportunity to encourage and further support our community!  

On this partner page you will see information regarding biomarker testing, RET fusion + lung cancer and immunotherapy and chemotherapy combinations. 

To learn more about Lilly Oncology please visit www.LillyOncology.com.

To join the conversation, visit our forums at https://cancergrace.org/forum.

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...

Hi Stan!  So good to hear from you.  I'm sorry for the late response.  I too have been out of town with family and missed your post, probably because I was...

It is so good to hear from you!  And I am so happy to hear that your holidays have been good and that you are doing well.  It sounds like your...

Recent Comments

JOIN THE CONVERSATION
Biomarkers
By JanineT GRACE … on
Radiation Therapy
By JanineT GRACE … on
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
Hi Stan!! and happiest of holidays!
By dbrock on